Jun 18, 2026 08:05AM
Jun 18, 2026 08:05AM
Jun 9, 2026 08:05AM
Jun 9, 2026 08:05AM
Jun 2, 2026 08:06AM
Jun 2, 2026 08:05AM
May 18, 2026 08:39AM Scienture reports 449% revenue growth in first quarter 2026
May 18, 2026 08:38AM
May 7, 2026 08:06AM
May 7, 2026 08:05AM
May 7, 2026 08:05AM
May 7, 2026 08:05AM
May 6, 2026 08:05AM
May 6, 2026 08:05AM SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041
Apr 15, 2026 08:05AM
Apr 15, 2026 08:05AM
Apr 6, 2026 08:06AM
Apr 6, 2026 08:05AM
Mar 30, 2026 08:08AM
Mar 30, 2026 08:07AM
Mar 11, 2026 08:06AM Scienture expands naloxone spray access through GPO deals
Mar 11, 2026 08:05AM
Feb 3, 2026 08:06AM
Feb 3, 2026 08:05AM
Jan 14, 2026 08:06AM
Jan 14, 2026 08:05AM
Dec 22, 2025 08:05AM
Dec 22, 2025 08:05AM SCIENTURE Provides Update on the Commercial Launch of REZENOPY®, the Highest Strength Naloxone HCl Life-Saving Opioid Overdose Emergency Treatment Approved by the FDA
Dec 10, 2025 08:05AM
Dec 10, 2025 08:05AM
Nov 13, 2025 08:05AM
Nov 4, 2025 08:05AM
Nov 4, 2025 08:05AM
Oct 23, 2025 08:05AM
Oct 23, 2025 08:05AM SCIENTURE Announces Start of Commercial Sales and Fulfillment of First Orders for Arbli™ (Losartan Potassium)
Oct 1, 2025 09:00AM
Sep 16, 2025 08:05AM
Sep 16, 2025 08:05AM
Jul 16, 2025 08:15AM
Jul 16, 2025 08:15AM
Jun 17, 2025 08:05AM
Jun 17, 2025 08:05AM Scienture Holdings Announces Cancelation of ELOC
May 22, 2025 08:20AM
May 22, 2025 08:05AM
Apr 3, 2025 08:26AM
Apr 3, 2025 08:26AM
Mar 25, 2025 08:05AM
Mar 25, 2025 08:05AM
Mar 19, 2025 08:05AM Scienture Holdings Announces Draw on ELOC, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading Days
Dec 10, 2024 08:06AM

323,584 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All